3:
Human epidermal growth factor receptor 2 status correlates with lymph node involvement in patients with estrogen receptor (ER) negative, but with grade in those with ER-positive early-stage breast cancer suitable for cytotoxic chemotherapy.
Bartlett JM, Ellis IO, Dowsett M, Mallon EA, Cameron DA, Johnston S, Hall E, A'Hern R, Peckitt C, Bliss JM, Johnson L, Barrett-Lee P, Ellis P.
J Clin Oncol. 2007 Oct 1;25(28):4423-30.
PMID: 17906205 [PubMed - indexed for MEDLINE]
Related Articles
5:
Routine assessment of hormonal receptor and her-2/neu status underscores the need for more therapeutic targets in Kenyan women with breast cancer.
Nyagol J, Nyong'o A, Byakika B, Muchiri L, Cocco M, de Santi MM, Spina D, Bellan C, Lazzi S, Kostopoulos I, Luzi P, Leoncini L.
Anal Quant Cytol Histol. 2006 Apr;28(2):97-103.
PMID: 16637512 [PubMed - indexed for MEDLINE]
Related Articles
8:
Quantitative association between HER-2/neu and steroid hormone receptors in hormone receptor-positive primary breast cancer.
Konecny G, Pauletti G, Pegram M, Untch M, Dandekar S, Aguilar Z, Wilson C, Rong HM, Bauerfeind I, Felber M, Wang HJ, Beryt M, Seshadri R, Hepp H, Slamon DJ.
J Natl Cancer Inst. 2003 Jan 15;95(2):142-53.
PMID: 12529347 [PubMed - indexed for MEDLINE]
Related Articles
11:
Differential amplification and overexpression of HER-2/neu, p53, MIB1, and estrogen receptor/progesterone receptor among medullary carcinoma, atypical medullary carcinoma, and high-grade invasive ductal carcinoma of breast.
Xu R, Feiner H, Li P, Yee H, Inghirami G, Delgado Y, Perle MA.
Arch Pathol Lab Med. 2003 Nov;127(11):1458-64.
PMID: 14567723 [PubMed - indexed for MEDLINE]
Related Articles
12:
LEA-135 expression: its association with a lower risk of recurrence and increased overall survival of patients with lymph node-positive primary invasive breast cancer.
Saha B, Zhang N, Naritoku WY, Tsao-Wei DD, Groshen SL, Carlsson G, Larsson L, Gustavsson B, Chaiwun B, Taylor CR, Imam SA.
Anticancer Res. 2004 Jul-Aug;24(4):2391-400.
PMID: 15330189 [PubMed - indexed for MEDLINE]
Related Articles
14:
Do we need HER-2/neu testing for all patients with primary breast carcinoma?
Taucher S, Rudas M, Mader RM, Gnant M, Dubsky P, Bachleitner T, Roka S, Fitzal F, Kandioler D, Sporn E, Friedl J, Mittlböck M, Jakesz R.
Cancer. 2003 Dec 15;98(12):2547-53.
PMID: 14669272 [PubMed - indexed for MEDLINE]
Related Articles